Performance History
| Key Stats | |
|---|---|
| Open | $1.46 |
| Prev. Close | $1.43 |
| EPS | -3.42 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | 9613286.00 |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 1.35 | 1.46 |
| 52 Week Range | 1.20 | 7.13 |
| Ratios | |
|---|---|
| P/B Ratio | 0.80 |
| Revenue | - |
| Operating M. % | -16,687.47% |
| Earnings | $0.00 |
| Earnings Growth % | 22.06% |
| EBITDA Margin % | - |
| ROEÂ % | -105.30% |
| EPS | -3.42 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
All Score 75 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.
| BRTX | MARKET | |
|---|---|---|
| Value | 76 | 38 |
| Quality | 60 | 40 |
| Ownership | 14 | 17 |
| Growth | 64 | 46 |
| Dividends | - | 37 |
BioRestorative Therapies's Price discount from all time high of 100% is great compared to market average of 41.5%. This indicates BRTX could be a good value stock.
Financial Forecast
AI Price Prediction
Analyst Ratings
Correlated Companies
About BioRestorative Therapies (BRTX)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Lance Alstodt
- Headquarters
- Melville
- Employees
- 10
- Exchange
- NASDAQ
Keep an eye on BioRestorative Therapies
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
What is BioRestorative Therapies's (BRTX) price per share?
The current price per share for BioRestorative Therapies (BRTX) is $1.37. The stock has seen a price change of -$0.06 recently, indicating a -4.2% change. This reflects the stock's recent market performance and investor sentiment.
What is the 52-week high and low for BioRestorative Therapies (BRTX)?
For BioRestorative Therapies (BRTX), the 52-week high is $7.13, which is 420.44% from the current price. The 52-week low is $1.2, the current price is 14.17% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
Is BioRestorative Therapies (BRTX) a growth stock?
BioRestorative Therapies (BRTX) has shown an average price growth of 0.41% over the past three years. It has received a score of 5 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying BioRestorative Therapies as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
What is BioRestorative Therapies (BRTX) stock price performance year to date (YTD)?
As of the latest data, BioRestorative Therapies (BRTX) has a year-to-date price change of -20.35%. Over the past month, the stock has experienced a price change of 4.18%. Over the last three months, the change has been -5.52%. Over the past six months, the figure is -22.97%.
Is BioRestorative Therapies (BRTX) a profitable company?
BioRestorative Therapies (BRTX) has a net income of -$14.42M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -16.69K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 21.7%, providing insight into the company's sales performance and growth. Operating income is noted at -$15.22M. Furthermore, the EBITDA is -$15.06M.
What is the market capitalization of BioRestorative Therapies (BRTX)?
BioRestorative Therapies (BRTX) has a market capitalization of $9.61M. The average daily trading volume is 1.92M, indicating the stock's liquidity and investor engagement.
News
Xiaomi and Samsung Smartphones Identified Among Top Radiation Emitters in 2024
Traders Pile Up Short Positions as Grayscale Abandons Ethereum Futures ETF Plan
Global Smartphone Shipments Jump by 20 Million Units Year-over-Year in Q1 2024
Pixel 8a Unveiled: Google’s AI Revolution Goes Mainstream
Visa’s Quarterly Revenue Jumped by $800 Million YoY and Hit an All-Time High of $8.75 Billion
Samsung Overtakes Apple in Q1 2024 Mobile Phone Shipments with 20.8% Market Share
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.